Zobrazeno 1 - 10
of 44
pro vyhledávání: '"J. Gossellin"'
Publikováno v:
Journal of Dairy Science. 93:1065-1068
The objective was to conduct a survey of current fresh cow management practices that have an effect on health and diseases postpartum considering different herd sizes of commercial dairy farms. A mail survey regarding aspects of the fresh cow program
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4049083dbef80213305a04a8b45e219d
https://doi.org/10.3168/jds.2009-2783
https://doi.org/10.3168/jds.2009-2783
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics. 30:1-10
Canine patients are generally regarded as being clinically obese when their body weight is at least 15% above ideal. The incidence of obesity in dogs is thought to be in the range of 20-40% of the general population and, since obesity is known to pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcc4e81c00aa0c05f21f3c2bb80ee4d5
https://doi.org/10.1111/j.1365-2885.2007.00863.x
https://doi.org/10.1111/j.1365-2885.2007.00863.x
Publikováno v:
Veterinary Parasitology. 96:147-154
A study was conducted to evaluate the therapeutic efficacy of doramectin administered intramuscularly at a dose rate of 200 microg/kg to sheep harbouring naturally acquired infections of gastrointestinal nematodes and Oestrus ovis in the southwestern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b08931b96561aa2f7d5014b4b1c090f5
https://doi.org/10.1016/s0304-4017(00)00429-5
https://doi.org/10.1016/s0304-4017(00)00429-5
Autor:
J. Gossellin, Jo McKelvie, J. S. Eagleson, S. J. Sunderland, T.G Rowan, J. Sherington, J. A. Wren
Publikováno v:
Journal of veterinary pharmacology and therapeutics. 30
The clinical efficacy for weight loss and safety of dirlotapide in dogs were evaluated in two multi-centre studies with parallel designs. Overweight, adult dogs (n = 245) of various breeds were randomized to treatment with dirlotapide or placebo in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::615f273d5a2736ccb2ef972bd2dd5a09
https://pubmed.ncbi.nlm.nih.gov/17567517
https://pubmed.ncbi.nlm.nih.gov/17567517
Publikováno v:
Journal of veterinary pharmacology and therapeutics. 30
The effects of dirlotapide on body weight (BW) reduction were investigated in overweight Labradors in two parallel-design studies. Study A involved 42 dogs randomized to 0.0, 0.025, 0.05, 0.1, 0.2 or 0.4 mg dirlotapide/kg/day orally for 4 weeks. Stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff85cd76a07fe5156be4e80c594abbd7
https://pubmed.ncbi.nlm.nih.gov/17567515
https://pubmed.ncbi.nlm.nih.gov/17567515
Autor:
J. S. Eagleson, A. A. Ramudo, S. J. Sunderland, J. A. Wren, S. L. Campbell, V. L. King, J. Gossellin
Publikováno v:
Journal of veterinary pharmacology and therapeutics. 30
Dirlotapide was evaluated in the management of obesity in dogs in two multicenter, clinical studies in North America. A total of 335 obese dogs of various breeds were randomized to dirlotapide or placebo in a 2:1 ratio. Dirlotapide was administered o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfeff4e9388785966bb90a9e28172cc2
https://pubmed.ncbi.nlm.nih.gov/17567518
https://pubmed.ncbi.nlm.nih.gov/17567518
Autor:
V. L. King, J. A. Wren, M. J. Krautmann, M. A. Hickman, J. Gossellin, T. J. Schmahai, R. L. Kerlin
Publikováno v:
Journal of veterinary pharmacology and therapeutics. 30
The safety of dirlotapide in dogs was evaluated in two studies with parallel designs. In an acute tolerance study, 24 beagles (six dogs per treatment) were treated orally once daily for 14 days with placebo or dirlotapide at 2.5, 5.0, or 10.0 mg/kg/d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21f21c438a86c7280f2706ac8a5283d6
https://pubmed.ncbi.nlm.nih.gov/17567514
https://pubmed.ncbi.nlm.nih.gov/17567514
Publikováno v:
Journal of veterinary pharmacology and therapeutics. 30
Dirlotapide is a microsomal triglyceride transfer protein (MTP) inhibitor developed specifically for canine weight reduction. MTP catalyzes the assembly of triglyceride-rich apolipoprotein-B containing lipoproteins to form chylomicrons in the intesti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f22d32f6c106c122d1d995d88a0bb43e
https://pubmed.ncbi.nlm.nih.gov/17567510
https://pubmed.ncbi.nlm.nih.gov/17567510
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.